Found 181 matching trials
SIRT With Tremelimumab and Durvalumab for Resectable HCC PHASE1 The goal of this research study is to evaluate the safety and tolerability ...
Show More Status
Active Not Recruiting
Location
Cedars-Sinai Medical Center
Learn More & Join Trial
Treat Primary and Metastatic Liver Tumors N/A The use of Radiospheres in the management of intrahepatic cholangiocarcinom...
Show More Location
Multiple Locations
Learn More & Join Trial
Clinical Validation of a Fractional Administration Device for Holmium-166 SIRT NA To investigate the in vivo performance and safety of a novel medical device...
Show More Learn More & Join Trial
Defining the Ablative Dose for Y-90 TARE PHASE2 This study is being done to help doctors improve how they treat liver tumor...
Show More Location
Northwestern University
Learn More & Join Trial
Pasireotide, Everolimus and Selective Internal Radioembolization Therapy for Unresectable Hepatic Metastases PHASE1 The purpose of this study is to see the safety and activity of using pasire...
Show More Location
Emory University Winship Cancer Institute
Learn More & Join Trial
Immunotherapy With Y90-RadioEmbolization for Metastatic Colorectal Cancer PHASE1 This clinical trial will be conducted as a single-center, open-label, Phase...
Show More Location
University of Iowa Hospitals and Clinics
Learn More & Join Trial
Precision Medicine in Patients With Unresectable CholAngiocarcinoma: RadioEmbolization and Combined Biological Therapy PHASE2 Underlying disease mechanisms are fundamental for correct treatment selecti...
Show More Location
Department of Radiology, IRCCS Ospedale San Raffaele
Learn More & Join Trial
Tas-102 and Radioembolization With 90Y Resin Microspheres for Chemo-refractory Colorectal Liver Metastases PHASE1 This is a phase I dose escalation study (3+3 design) with a dose expansion ...
Show More Location
University of California San Francisco
Learn More & Join Trial
Streamlining Radioembolization for Small HCC N/A In patients who has no sign suggesting high lung shunt fraction (TIPS, hepa...
Show More Location
National Cancer Center
Learn More & Join Trial
Study of Lanreotide in Patients With Metastatic Gastrointestinal Neuroendocrine Tumors Who Are Undergoing Liver-directed Radioembolization With Yttrium-90 Microspheres PHASE2 Neuroendocrine tumors (NETs) and cancers that originate from the gastrointe...
Show More Location
Rocky Mountain Cancer Center
Learn More & Join Trial